Antibiotic antibiotic therapy. The antibiotic treatment may select for bacterial strains with physiologically or genetically enhanced capacity to survive high doses of antibiotics. Under certain conditions, it may result in preferential growth of resistant bacteria, while growth of susceptible bacteria is inhibited by the drug. For example, antibacterial selection for strains having previously acquired antibacterial-resistance genes was demonstrated in 1943 by the Luria–Delbrück experiment. Antibiotics such as penicillin and erythromycin, which used to have a high efficacy against many bacterial species and strains, have become less effective, due to the increased resistance of many bacterial strains. Resistance may take the form
Antibiotic use in livestock for not collecting enough information and data on antibiotic use in factory farms. From this, the GAO concluded that the FDA does not have enough information to create effective policy changes regarding antibiotic use. In response, the FDA insisted that more research was being conducted and voluntary efforts within the industry would solve the problem of antibiotic resistance. Few policies exist that limit antibiotic use on factory farms, and some proposed legislation in the US has failed to be adopted. In 2007, two federal bills (S. 549 and H.R. 962) aimed to phase out nontherapeutic antibiotics in U.S. food animal